Editing Mark Whitacre (section)

==Career==
Whitacre was a PhD scientist at [[Ralston Purina]] after he graduated from Cornell University in early 1983. He then was Vice President at [[Evonik]] from 1984 to 1989 prior to joining ADM. In late 1989, Whitacre became the President of the BioProducts Division at ADM. In 1992, he was promoted to Corporate Vice President of ADM, as well as being President of the BioProducts Division. On August 9, 1995, Whitacre was terminated for conducting a $9.5 million fraud after ADM learned that he was an FBI informant for three years. Whitacre wore a wire for the FBI assisting in one of the largest price fixing cases in U.S. history, against ADM.<ref name="Henkoff"/>

After leaving ADM in August 1995, Whitacre was hired as the CEO of Future Health Technologies (FHT), which soon was renamed Biomar International. He worked at Biomar until his incarceration began during early 1998.{{sfn|Lieber|2000|p=379}}

In December 2006, after his release from federal prison, Whitacre was hired by Cypress Systems Inc., a California biotechnology company, as the President of Technology and Business Development.<ref name="Clemency"/> In March 2008, Whitacre was promoted to the company's Chief Operating Officer (COO) and President of operations.<ref name="Forbes">{{Harvnb|Ackerman|2008}}</ref>